NBNicole A. Borchard Ba

Nicole A. Borchard Ba

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nicole A. Borchard Ba has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Angela Yang

    Division of Rhinology, Department of Otolaryngology – Head and Neck Surgery Stanford University School of Medicine Palo Alto California U.S.A.

    1 shared publication
  • Ashoke Khanwalkar

    Division of Rhinology, Department of Otolaryngology – Head and Neck Surgery Stanford University School of Medicine Palo Alto California U.S.A.

    1 shared publication
  • Dayoung Kim

    Division of Rhinology, Department of Otolaryngology – Head and Neck Surgery Stanford University School of Medicine Palo Alto California U.S.A.

    1 shared publication
  • Jayakar V. Nayak

    Department of Otolaryngology, Head and Neck Surgery Stanford University School of Medicine Stanford California USA

    1 shared publication
  • Matt Lechner

    Division of Rhinology, Department of Otolaryngology – Head and Neck Surgery Stanford University School of Medicine Palo Alto California U.S.A.

    1 shared publication
  • Michael T. Chang

    Department of Otolaryngology–Head and Neck Surgery Stanford University School of Medicine Stanford California USA

    1 shared publication

Latest Publications

  • Long‐Term Outcomes of Inferior Meatus Augmentation Procedure to Treat Empty Nose Syndrome

    by Sachi S. Dholakia, Angela Yang, Dayoung Kim, Nicole A. Borchard Ba, Michael T. Chang, Ashoke Khanwalkar, Matt Lechner, Jayakar V. Nayak

    Objectives/Hypothesis: We sought to report the long‐term, symptom‐focused, prospective outcomes in empty nose syndrome (ENS) patients after undergoing inferior meatus augmentation procedure (IMAP) through use of four validated questionnaires: Empty Nose Syndrome 6‐Item Questionnaire (ENS6Q), 22‐item Sino‐Nasal Outcome Test (SNOT‐22), Generalized Anxiety Disorder 7‐Item Scale (GAD‐7), and Patient Health Questionnaire‐9 (PHQ‐9).Study Design: Prospective case series.Methods: A single‐center prospective case series was performed for patients diagnosed with ENS who underwent IMAP between July 2017 and February 2020. Diagnosis of ENS was based on the following criteria: 1) reported discomfort with nasal breathing and/or paradoxical nasal obstruction after inferior turbinate reduction, 2) a positive ENS6Q score of at least 11, and 3) a positive cotton test. Questionnaire responses were recorded prior to surgery as well as 1, 3, 6, and 12 months postoperatively.Results: Seventeen eligible patients were included. Mean ENS6Q scores were significantly reduced at all postoperative time points (p < .0001, p < .0001, p < .0001, p = .0003). Of the six ENS6Q subdomains, five (suffocation, dryness, sense of diminished airflow, nasal crusting, and nasal burning) were significantly reduced 1‐year postoperatively (p < .0001, p = .0004, p = .0136, p = .0114, p = .0080, respectively). SNOT‐22 scores were significantly reduced at all time points (p = .0021, p = .0227, p = .0004, and p = .0025). Of the SNOT‐22 subdomains, the sleep subdomain was significantly reduced 1‐year postoperatively (p = .0432). Low baseline GAD‐7 and PHQ‐9 scores were recorded at 7 and 9.4, respectively, and although scores at all postoperative time points were reduced, there was no statistical significance.Conclusion: IMAP via implant of cadaveric rib cartilage provides significant, long‐term improvements in ENS‐specific and general sinonasal symptoms.Level of Evidence: 4 Laryngoscope, 131:E2736–E2741, 2021